Subhabrata Sanyal

Subhabrata Sanyal is a Principal Pharmacologist at Calico. Subhabrata was previously a Principal Investigator at Biogen, where they led a research team within the Neurology group to establish an early target discovery pipeline in Parkinson's disease. Subhabrata has also taught courses in Molecular Biology, Genetics and Neuroscience at the graduate and medical school levels. Subhabrata did their post-doctoral work at The University of Arizona.

Subhabrata Sanyal received a Ph.D. in molecular neuroscience from the Tata Institute of Fundamental Research (TIFR). Subhabrata also holds a Master of Science (M.Sc.) in biotechnology from Madurai Kamaraj University (MKU) and a Bachelor's Degree in zoology from Delhi University.

Their manager is Aarif Khakoo, Head of Drug Development. They work with Ganesh Kolumam - Head of Physiology, Emmanuelle Bellemin - Head of Regulatory Affairs, and Aide Castro - Director, Clinical Operations.